The transaction, expected to close by the end of 2021, is the largest in PerkinElmer’s history.
Under the deal, BioLegend’s San Diego campus will become PerkinElmer’s global center of excellence for research reagent content development.
BioLegend has estimated 2022 revenue of $380 million.
Read the full news release here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
